Met Life Investment Management, LLC Maxcyte, Inc. Transaction History
Met Life Investment Management, LLC
- $16.6 Billion
- Q2 2024
A detailed history of Met Life Investment Management, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 60,983 shares of MXCT stock, worth $220,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,983
Previous 47,668
27.93%
Holding current value
$220,758
Previous $199,000
20.1%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
65MCall Options Held
600Put Options Held
2.7K-
Black Rock Inc. New York, NY8.14MShares$29.5 Million0.0% of portfolio
-
Cadian Capital Management, LP New York, NY7.62MShares$27.6 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.65MShares$20.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$18.7 Million0.01% of portfolio
-
Vitruvian Partners LLP5.04MShares$18.3 Million5.8% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $368M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...